CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NKGen Biotech Korea Co ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NKGen Biotech Korea Co ltd
440, Changnyong-daero, Yeongtong-gu
Phone: +82 316039218p:+82 316039218 SUWON, 16504  South Korea Ticker: 182400182400
This company was Merged or Acquired on 9/4/2025.
This is a Subsidiary, click here for the Parent Company
Business Summary
NKGen Biotech Korea Co Ltd, formerly NKMax Co Ltd is a Korea-based company primarily engaged in the research, development, manufacturing, and supply of biological products. The company operates immune cell therapy, immunodiagnostic kits, health functional food sales, and bioresearch reagent businesses.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yong ManKim 59 8/13/2025 8/13/2025
Managing Director Yong HwanCho 43
Internal Auditor Yin SeokGoh 57 11/21/2025 11/21/2025
6 additional Officers and Directors records available in full report.

Business Names
Business Name
182400
NKMax America, Inc.

General Information
Number of Employees: 86 (As of 12/31/2015)
Outstanding Shares: 71,377,414 (As of 1/29/2026)
Shareholders: 44,835
Stock Exchange: KDQ
Fax Number: +82 3180178124


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, February 1, 2026